Taiyen Biotech Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 865 million compared to TWD 923.15 million a year ago. Net income was TWD 108.13 million compared to TWD 127.24 million a year ago.

Basic earnings per share from continuing operations was TWD 0.54 compared to TWD 0.64 a year ago. Diluted earnings per share from continuing operations was TWD 0.54 compared to TWD 0.64 a year ago.